Brief: Adaptimmune Therapeutics Secures Up To $125 Million Debt Financing With Hercules Capital
15/05/2024 12:22
May 15 (Reuters) - Adaptimmune Therapeutics PLC
ADAP.O :
* ADAPTIMMUNE THERAPEUTICS PLC - SECURES UP TO $125 MILLION
DEBT
FINANCING WITH HERCULES CAPITAL
* ADAPTIMMUNE THERAPEUTICS PLC - HAS ENTERED INTO $125
MILLION
FIVE-YEAR, TERM LOAN FACILITY WITH HERCULES CAPITAL, INC
* ADAPTIMMUNE THERAPEUTICS-FIRST TRANCHE OF $25 MILLION
AVAILABLE
UPON CLOSING; CO WILL BE ELIGIBLE TO DRAW ADDITIONAL $25 MILLION
SUBJECT TO AFAMI-CEL APPROVAL
Source text for Eikon: ID:n0001558370-24-008208
Further company coverage: ADAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptimmune Therapeutics
See all newsAdaptimmune Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview